Wealth Enhancement Trust Services’s Organogenesis Holdings ORGO Stock Holding History

Wealth Enhancement Trust Services’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04K	Buy	+428	New	+$1.05K	﹤0.01%	1123

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wealth Enhancement Trust Services's ORGO Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 428 shares worth $1.04K. The stake represents ﹤0.01% of the portfolio and ranks #1123 among its holdings.

74 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Wealth Enhancement Trust Services held 428 shares of Organogenesis Holdings worth $1.04K as of Q2 2026.
Organogenesis Holdings was a new Wealth Enhancement Trust Services position in Q2 2026.
Organogenesis Holdings made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1123 holding.
74 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.